Roche pays $1.7 billion to target tumors' genetic signatures

Nature Biotechnology 36, 123 (2018).
doi:10.1038/nbt0218-123

Source: Nature Biotechnology - February 6, 2018 Category: Biotechnology Tags: News Source Type: research